XB-PHENO-16518
Xla.wt + dab2 MO, Shang N et al. (2020)
Experiment + Assay: |
Xla.wt + dab2 MO +
NF31
|
Manipulations: |
Manipulation Type |
Reagent |
Target Gene |
Stage |
Treatment Area |
morpholino injection
|
dab2 MO3
|
dab2 (Xla)
|
NF stage 2 (2-cell)
|
blastomere
|
morpholino injection
|
dab2 MO4
|
dab2 (Xla)
|
NF stage 2 (2-cell)
|
blastomere
|
|
|
Expression Phenotypes (9):
|
decreased amount
actn4.L
expression in myotome
|
decreased amount
mef2c.L
expression in myotome
|
decreased amount
myf5.L
expression in dermomyotome
|
decreased amount
myf5.L
expression in hyoid arch
|
decreased amount
myf5.L
expression in hypaxial muscle
|
decreased amount
myod1.L
expression in myotome
|
decreased amount
myos.L
expression in myotome
|
decreased amount
pax3.L
expression in hypaxial muscle
|
decreased amount
pax3.L
expression in myotome
|
|